NEW YORK, Sept 26 – By earmarking $100 million for investments in genomics start-ups, Compaq Computer Corporation (NYSE: CPQ) is poised to earn big returns from picking winners as well as from generating increased revenues by creating more demand for its computers, experts said Tuesday.

“The more that these computer companies can drive genetic sciences and bioinformatics, the more computers they can sell,” said Alexander Hittle, genetic sciences analyst at AG Edwards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.